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The relationship between the major histocompatibility systems as defined sero- 
logically and by the mixed leukocyte culture (MLC) test is one which has received 
attention in both man (1) and mouse (2). In man, studies within families suggest 
that cells of siblings who inherit the same HL-A chromosomes from their parents 
and thus are serologically identical at HL-A do not stimulate in the MLC test. 
Cells of siblings who inherit different HL-A chromosomes do stimulate. This, 
combined with the finding that cells of all of several hundred unrelated pairs 
stimulate in the MLC test, suggests that a single genetic system controls reactivity 
in MLC, that this system is highly polymorphic and either the same as that coding 
for the HL-A antigens or very closely linked to the HL-A (1). Similarly, differ- 
ences at the H-2 system in the mouse result in MLC activation (2). 
The H-2 system in the mouse can be divided into two separate regions, H-2K 
and H-2D (3). Recently Rychlikova et al. (4) studied a series of mouse recombi- 
nant strains that differed only for the H-2D region or only for the H-2K region 
and other inbred strains that differed at both the H-2D and the H-2K regions. 
Their findings suggested that differences for H-2K alone or for both H-2K and 
H-2D resulted in MLC activation. Differences for the H-2D region alone. however, 
did not result in MLC activation in their study. 
We have repeated these studies using a number of recombinant strains tested in 
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all possible combinations of two in one-way mixed leukocyte culture tests (5). 
Our findings show unequivocally that whereas the H-2K region differences are 
associated with stronger MLC stimulation on the average than H-2D region differ- 
erences, some H-2D region differences by themselves do result in significant stim- 
ulation in I\ILC. 
METHOD 
The method used for culturing will be described in detail elsewhere (6 j ; however, 
a brief description follows. Mouse spleen cells are cultured in RPMI-1640 (Gibco, 
Grand Island, NY), supplemented with penicillin, 100 units/ml ; streptomycin, 
100 pg/ml and heat-treated (56”C, 30 min) human plasma obtained from a frozen 
pool, 5 ml/100 ml (7). Responding cells and mitomycin C-treated stimulating cells 
(5) are cultured in O.&ml vol in Linbro microtiter plates (IS-FB-96-TC) at 
individual concentrations of lo6 cells/well. After 72 hr of incubation in a humidi- 
fied 5% CO,, 957 0 air atmosphere, 2 $Zi tritiated thymidine (sp act 1.9 Ci/mmole ; 
Schwartz Bioresearch, Orangeburg, NY) is added to quadruplicate cultures. Six- 
teen hours later, samples are precipitated onto glass fiber filters and assayed for 
uptake of 3H-TdR by liquid scintillation spectrophotometry (8). 
Six of the 16 strains of mice used in these experiments are listed in Table 1 ; 
each combination has been tested a minimum of four times in MLC tests. All are 
congenic on a C57Bl/lO background; thus, any differences found between them 
can be ascribed to differences for the H-2 chromosomal region. 
RESULTS 
MLC test results on some of these strains are given in Table 2. These results 
were selected to demonstrate various points; they are representative of results 
obtained with other strain combinations as well as results obtained in other experi- 
ments. Six strains tested in all combinations of two are shown. Counts per minute 
(cpm) of tritiated thymidine incorporated ? standard deviation are given. In 
addition, the H-2 difference in each combination is given as either H-2K region 
alone, H-2D region alone, or H-2K and H-2D region differences. Lastly, for 
each combination it is indicated whether the stimulation in the allogeneic combina- 
tion is statistically different from that in the isogeneic control culture using the 
same responding cell. This calculation is based on a t test performed on the log- 
‘TABLE 1 








Alleles at loci 
H-2 
Abbreviation chromosome H-2K H-2D 
BlO b b b 
A a k d 
BR k Ii I-c 
3R i-Sg b d 
4R h-2Sg Ii b 
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converted data. Strains 3R and 5R are identical for the H-2K and H-2D regions 
and the cells do not stimulate each other. 
DISCUSSION 
Two general statements can be made. First, cells of mice that differ for either 
the H-2K region alone or for the H-2D plus the H-2K region stimulate more in 
MLC than do cells of mice that differ only for the D region. All of these combina- 
tions can result in significant stimulation. Second, cells of mice that differ only 
for the H-2D region stimulate in some cases and do not stimulate in other cases. 
The stimulation in some of these instances is highly significant and is reproducible 
from experiment to experiment. 
Several of the mouse strain combinations tested in MLC in this study have also 
had skin graft survival studies done. The results of those studies (9) showed that 
in four combinations in which there was a H-21( region difference skin grafts 
were rejected in 10.1-11.7 days, whereas when an H-2D region difference was 
present skin grafts were rejected in 14-17 days. As noted above we have found 
greater stimulation when H-2K region differences were involved than when H-2D 
region differences were involved. There is thus an overall correlation between the 
results of skin graft survival and MLC activation. Whereas we do not believe that 
MLC data for one given combination is optimally presented by studying ratios of 
cpm present in the allogeneic mixture divided by the cpm present in the control 
isogeneic mixture, it would seem useful here to summarize the MLC results from 
three experiments. All combinations in which skin grafting was done that differed 
only for the H-2D region had a ratio of MLC stimulation between 0.9 and 2.9 
with an average ratio of 1.55 ; combinations differing for the H-2K region had 
stimulation ratios varying from 3.4 to 15.4 with a mean ratio of 6.77. 
These results confirm the findings of Rychlikova et al. (4) that H-2K region 
differences do result in greater stimulation on the average than do H-2D region 
differences. However, they also indicate that certain H-2D region incompatibilities 
are associated with stimulation in MLC. Rychlikova et al. pointed out in their 
article that the lack of stimulation in MLC when there were only H-2D region 
differences may have been due to insensitivity of their MLC method. We would 
agree that this is a likely reason for the difference in our findings. 
The observation that H-2D region differences alone do result in MLC activation 
is theoretically and practically important. In the original studies in which the 
HL-A-MLC correlation was described, one sibling pair was studied, the members 
of which had inherited the same HL-A chromosomes from their parents and thus 
had the same HL-A antigens. The cells of these two siblings, however, did stimulate 
in the MLC. We suggested at that time (1) that as one possible explanation of this 
finding there may be another locus linked to HL-A, differences at which could 
also cause stimulation in MLC. In one parent of this sibling pair a recombinational 
event would have taken place making the two siblings different at this other locus- 
thus the MLC activation. Recently, Yunis and Amos (10) have suggested that 
such a third locus, linked to HL-A in man, may, in fact, be the MLC locus. In 
anology with mice one could thus explain the stimulation associated with H-2K 
region differences by suggesting that if mice differ for the H-2K region, they wih 
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also differ at this MLC locus (the MLC locus being on that side of H-2) and, 
therefore, there is a positive MLC. H-2D region differences would not result in 
stimulation since there is no difference for the MLC locus. The finding of clearly 
positive MLC tests in some H-2D region differences in this study is pertinent to 
this problem. We have used the term “region” when referring to H-2K or H-2D 
differences since it seems possible that genes linkd to but separate from the H-2K 
and H-2D loci can cause stimulation in MLC ( 11). 
Very preliminary, since few combinations are involved, is the correlation between 
skin graft survival and MLC activation. This correlation needs to be strengthened 
by further studies. 
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